Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 1 results out of 1                                
                                
                                                Data Insights
                                                
                                        BMS-986368 by Bristol-Myers Squibb for Epilepsy: Likelihood of Approval
BMS-986368 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Epilepsy. According to GlobalData, Phase I...